In recent years, the emergence of digital tools and technologies has brought significant change in clinical research and trials. While traditional clinical trials have long been the gold standard for evaluating medical interventions, the proliferation of digital solutions has introduced complexities in managing multiple systems, data silos, and non-interoperable platforms. The patient and sponsor experiences suffer due to the presence of multiple disjointed systems and interfaces, leading to challenges in accessing and managing medical information. These challenges have sparked an urgent need to develop a unified approach that can streamline clinical trials and seamlessly integrate diverse technologies and data sources.
The vision of a unified approach to transform clinical trials is fueled by the recognition of these challenges and the understanding that embracing digital technologies alone is not enough. To fully harness the potential of these tools, a cohesive and harmonized ecosystem is required, one in which data flows seamlessly, and technologies complement each other.
This viewpoint offers a comprehensive view on a unified platform approach in clinical development, highlighting the key business challenges that enterprises face and the advantages of adopting such platforms. The report also outlines the architecture of these unified clinical development platforms and the benefits they offer to various stakeholders. Additionally, it provides a framework for life sciences companies to transition to this approach and offers recommendations for a successful implementation.
Scope
Industry: life sciences
Geography: global
Contents
In this report, we present:
An overview of a unified platform approach to clinical development including key business challenges that enterprises face and the benefits of adopting such platforms
An overview of the architecture of a unified clinical development platform and stakeholder benefits that these platforms can unlock
A framework for life sciences enterprises to transition to a unified platform approach and recommendations for success
The COVID-19 outbreak compelled the life sciences industry to innovate and transform digitally. However, the current global macroeconomic and socio-political uncertainty, coupled with increasing research and development IT expenditure, have created…
